Suchergebnisse - "Bertamini, Luca"

PubPharm (24)

1

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.

enthalten in: bioRxiv.org | 2024

von Nadeem, O. | Aranha, M. | Redd, R. | +19

2

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial

enthalten in: EClinicalMedicine | 2023

von Zamagni, E. | Oliva, S. | Gay, F. | +28

3

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma : pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

enthalten in: The Lancet. Oncology | 2023

von Mina, R. | Musto, P. | Rota-Scalabrini, D. | +24

ErratumIn: Lancet Oncol. 2023 Feb;24(2):e72. - PMID 36725151

4

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Bertamini, L. | Oliva, S. | Rota-Scalabrini, D. | +26

CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3099-3102. - PMID 35759726

5

Beyond Clinical Trials in Patients With Multiple Myeloma : A Critical Review of Real-World Results

enthalten in: Frontiers in oncology | 2022

von Bertamini, L. | Bertuglia, G. | Oliva, S.

6

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE) : a randomised, open-label, phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Gay, F. | Musto, P. | Rota-Scalabrini, D. | +23

7

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Zaccaria, G. | Bertamini, L. | Petrucci, M. | +21

8

Whole-genome sequencing analysis of semi-supercentenarians

enthalten in: eLife | 2021

von Garagnani, P. | Marquis, J. | Delledonne, M. | +32

9

MRD Assessment in Multiple Myeloma : Progress and Challenges

enthalten in: Current hematologic malignancy reports | 2021

von Bertamini, L. | D'Agostino, M. | Gay, F.

10

MRD Assessment in Multiple Myeloma: Progress and Challenges

enthalten in: Current hematologic malignancy reports | 2021

von Bertamini, L. | D’Agostino, M. | Gay, F.